newsfilter
← Latest News
GlobeNewswire·

Cerevel Therapeutics Announces Proposed Private Offering of Convertible Senior Notes

CAMBRIDGE, Mass., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Cerevel Therapeutics Holdings, Inc. ("Cerevel", "we", "us" or "our") (NASDAQ:CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, announced today that it